DAVID W GRAINGER portrait
  • Distinguished Professor, Biomedical Engineering
  • Chair, Biomedical Engineering
  • Distinguished Professor, Molecular Pharmaceutics
  • Adjunct Professor of Orthopedics, Orthopaedic Surgery Operations
  • Adjunct Professor, Chemistry
  • Ole and Marty Jensen Endowed Professor, School Of Dentistry

Current Courses

Spring 2025

  • BME 4992-008
    Thesis Wrtg & Comm II
    Location: SMBB 2660 (SMBB 2660)
  • BME 7880-001
    TA Mentorship
  • BME 7990-001
    Cont Reg-Ph D
  • DENT 7131-001
    Oral Biology
    Location: UUSOD 2130 (UUSOD 2130)
  • PHCEU 7020-001
    Phys Chem of Biomedical

Fall 2024

Summer 2024

Entrepreneurial Experience

  • Elute Inc. 10/01/2011 - present. Employees: 5.
    Comments: start-up company based on university IP from my lab involving reservable antibiotic-releasing bone graft biomaterials; located in Research Park, has won 2 Utah State TCIP awards with match required and successful seed funding from UpStart Ventures, completed Series A2 round for $4.5 million; Series B round, FDA 510(k) approval for first graft product; FDA RFD granted device designation for drug-eluting product.

Professional Organizations

  • National Academy of Inventors. 12/01/2023 - present. Position : Fellow.
  • Alexander von Humboldt Foundation Society. 03/01/1990 - present. Position : Member.
  • International Federation of Societies of Biomaterials. 01/01/2004 - present. Position : Fellow.
  • American Association of Pharmaceutical Scientists. 01/01/2000 - present. Position : Member.
  • American Institute of Medical and Biological Engineers. 01/01/2000 - present. Position : Fellow.
  • Controlled Release Society. 01/01/1994 - present. Position : Member.
  • American Chemical Society. 01/01/1990 - present. Position : Member.
  • Society for Biomaterials. 01/01/1990 - present. Position : Member.

Additional didactic teaching

I regularly lecture across 5 different Schools/Colleges on campus and globally in graduate "summer schools", industrial workshops and special student focus groups.